Clinical Research:
University of New Mexico Psilocybin in the Treatment of Alcoholism
Harbor - UCLA Psilocybin & Cancer
New York University Psilocybin & Cancer
Johns Hopkins University Psilocybin & Cancer
Psilocybin in the Treatment of Obsessive-Compulsive Disorder
Basic Science Research:
Heffter-Zürich Center Psilocybin-Serotonin Receptor Research
Johns Hopkins University Psilocybin & Spirituality
Preclinical Research:
Behavioral, Molecular and Genetic Research
University of Arizona Medical Center

University of Arizona Medical Center.

View this study’s abstract: arrow

Support research like this: arrow

ALL HEFFTER SUPPORTED
RESEARCH arrow
OUR BOARD OF DIRECTORS arrow

Psilocybin in the Treatment of Obsessive-Compulsive Disorder

divider

This study is the first clinical use of a psychedelic in the United States in more than 30 years. All the patients were beyond the reach of standard treatments, and all responded well. One patient had symptom remission for weeks following one psilocybin session. This study shows a potential breakthrough treatment for obsessive-compulsive disorder, a recalcitrant disease that is the fourth most common outpatient psychiatric problem. The study was conducted by Dr. Francisco Moreno, M.D. at the University of Arizona Medical Center, and published in 2006.